Tpg Gp A, LLC Allogene Therapeutics, Inc. Transaction History
Tpg Gp A, LLC
- $4.18 Billion
- Q3 2024
A detailed history of Tpg Gp A, LLC transactions in Allogene Therapeutics, Inc. stock. As of the latest transaction made, Tpg Gp A, LLC holds 18,716,306 shares of ALLO stock, worth $47.7 Million. This represents 1.25% of its overall portfolio holdings.
Number of Shares
18,716,306Holding current value
$47.7 Million% of portfolio
1.25%Shares
1 transactions
Others Institutions Holding ALLO
# of Institutions
162Shares Held
134MCall Options Held
59.4KPut Options Held
113K-
Black Rock Inc. New York, NY16.4MShares$41.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.33MShares$21.2 Million0.0% of portfolio
-
State Street Corp Boston, MA7.01MShares$17.9 Million0.0% of portfolio
-
Capital World Investors Los Angeles, CA6.9MShares$17.6 Million0.0% of portfolio
-
Lynx1 Capital Management LP San Juan, PR6.2MShares$15.8 Million6.22% of portfolio
About Allogene Therapeutics, Inc.
- Ticker ALLO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 143,807,008
- Market Cap $367M
- Description
- Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...